Two CTI Executives Honored at C-Suite Awards

Paul Ritter is a finalist in the Chief Legal Officer category, and Kevin Schwarz is a finalist in the Chief Operating Officer category. 

"We are privileged to have such strong leaders on our team," remarks Tim Schroeder, CEO of CTI. "Both Paul and Kevin have played crucial roles in the growth and success of our company over the last 15 years, and we are thrilled to see this well-deserved recognition from the community."

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America.

Bexion and CTI Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer

“CTI is extremely happy to partner with Bexion on the development of this novel therapy in patients who desperately need alternative treatments,” stated William Aronstein, PhD, MD, FACP, Vice President, Medical Affairs at CTI. “They are an innovative organization with very strong regional ties – the drug was initially developed and licensed at a local hospital, early funding has predominantly come from the region, and the management and board have strong local connections.”

CTI Announces Continued Growth Across Europe and Asia

“The expansions in Taiwan and Japan are part of continued efforts to increase capacity for clinical research across Asia,” according to Patrick Earley, Vice President, International. “We have been working across Asia for a number of years, but felt like a more permanent presence in Taipei and Tokyo would further enhance relationships with local medical centers and biotechnology companies."

 

Regenerative Medicine / Gene Therapy

Find out how CTI can provide value to regenerative medicine and gene therapy programs as a leader in the field.

Learn More

Phase I Studies

The CTI CRC Phase I unit is a state-of-the-art facility designed specifically to conduct early phase clinical pharmacology trials.

Learn More

Simulation Models for Economic Evaluation

Participate in a Trial

Icon Careers Small Retina

CTI CRC is looking for volunteers to participate in our current trials. 

Learn More

Join our Team

Icon Briefcase Small Retina

CTI is always looking for talented individuals to join our team around the world!

Learn More